Selected 35 - Pedro Correa de Sampaio

We had the pleasure of interviewing Pedro Correa de Sampaio, the Co-Founder and CEO of Neobe Therapeutics. Neobe Therapeutics is a cutting-edge biotechnology startup that focuses on using engineered bacteria to combat drug resistance in cancer treatment. In this insightful conversation, Pedro shares the vision behind Neobe Therapeutics, the challenges faced in developing their innovative solutions, and their progress towards revolutionizing cancer therapy.